Announced Fri, 7 Nov · 21:47 IST

Approval of Unaudited results for the quarter and half year ender 30th September, 2025 for the FY 2025-26

Revenue Growth 20pctPat Growth 25pctResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board of Integrated Proteins Limited approved the unaudited financial results for the quarter and half year ended 30 September 2025. For Q2 FY26, revenue from operations stood at around Rs. 419.82 lakh with total income of about Rs. 424.54 lakh. The company reported a profit after tax of Rs. 5.03 lakh in Q2 FY26, compared to a loss of Rs. 3.14 lakh in Q2 FY25. For H1 FY26, PAT was Rs. 5.04 lakh versus a loss of Rs. 3.21 lakh in H1 FY25, indicating a turnaround. Total income for H1 FY26 was about Rs. 424.54 lakh against Rs. 8.04 lakh in H1 FY25 (suggesting lumpy/seasonal business). Reserves remain negative at Rs. (29.39) lakh but improved from Rs. (34.42) lakh at FY25 end. The statutory auditor B.B. Gusani & Associates issued a clean limited review report with no qualifications.

Likely market impact

The swing from loss to profit is a positive sign, though absolute earnings remain small and the company still carries negative reserves, indicating accumulated historical losses. Revenue remains uneven across quarters, so investors should not read the H1 surge as steady annualised growth.